Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
The British Journal of Radiology|September 19, 2025
Optimizing diagnostic pathways through digital multidisciplinary team management of patients with cancer of unknown primary: a retrospective analysisJeroen R J Willemse, Max J Lahaye, Petur Snaebjornsson, et al.
Clinical Nuclear Medicine|May 27, 2025
Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?Bernies van der Hiel, Wouter V Vogel, Alfons J M van den Eertwegh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patientsEsther G C Troost, Wouter V Vogel, Matthias A W Merkx, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Urology|January 29, 2014
18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancerLaura S Mertens, M Carmen Mir, Andrew M Scott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2025
[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trialSabine E Breukers, Robert D Crommelin, Laura A Smit, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2017
Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerMette S van Ramshorst, Suzana C Teixeira, Bas B Koolen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2014
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapyKenneth E Pengel, Bas B Koolen, Claudette E Loo, et al.
Cancers|June 10, 2023
Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment OptionsLotte G Zuur, Hilda A de Barros, Koen J C van der Mijn, et al.
Nuclear Medicine Communications|July 24, 2025
Malignancy classification of thyroid incidentalomas using 18F-fluorodeoxy-d-glucose PET/computed tomography-derived radiomicsMelda Yeghaian, Marceline W Piek, Annemarieke Bartels-Rutten, et al.
Pageof 22